cardiomyopathy
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Treatment with an adenoviral vector encoding <span class="gene" id="18083897-0-45-69">hepatocyte growth factor</span> mitigates established cardiac dysfunction in doxorubicin-induced <span class="disease" id="18083897-0-135-149">cardiomyopathy</span>.